You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

89Zr-DFO-REGN3767

Showing 26 - 50 of 128
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Clear Cell Renal Cell Carcinoma Trial in Worldwide (89Zr-girentuximab)

Recruiting
  • Clear Cell Renal Cell Carcinoma
  • 89Zr-girentuximab
  • Duarte, California
  • +29 more
Aug 4, 2021

Angelman Syndrome Trial in Groningen (RO7248824)

Completed
  • Angelman Syndrome
  • Groningen, Netherlands
    Pra International Group B.V
Sep 7, 2022

Subjects With Diabetes and DFU With a Suspicion of DFO Trial in Paris (Bedside blind bone biopsy procedure)

Not yet recruiting
  • Subjects With Diabetes and DFU With a Suspicion of DFO
  • Bedside blind bone biopsy procedure
  • Paris, France
    Bichat - Claude Bernard Hospital
Sep 28, 2023

Malignancies Trial in Worldwide (REGN3767, cemiplimab)

Active, not recruiting
  • Malignancies
  • Encinitas, California
  • +42 more
Aug 25, 2022

Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Stage IV Cutaneous Squamous Cell

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +2 more
  • Panitumumab
  • +4 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Feb 16, 2023

Leptomeningeal Metastases Trial in United States (Deferoxamine (DFO))

Recruiting
  • Leptomeningeal Metastases
  • Deferoxamine (DFO)
  • Basking Ridge, New Jersey
  • +6 more
Jun 27, 2022

Melanoma, Merkel Cell Carcinoma, Unspecified, Renal Cell Carcinoma Trial in Australia, Netherlands, United States

Recruiting
  • Melanoma
  • +3 more
  • 89Zr-Df-Crefmirlimab
  • Little Rock, Arkansas
  • +7 more
Jul 11, 2022

Cancer Trial in Wuxi (89Zr-NY009)

Recruiting
  • Cancer
  • Wuxi, China
    Affiliated Hospital of Jiangnan University
Jan 19, 2023

Prostate Cancer Trial in New York (huJ591)

Active, not recruiting
  • Prostate Cancer
  • New York, New York
    Weill Cornell Medical College
Apr 20, 2022

Multiple Myeloma Trial in Wuxi (89Zr-NY008)

Recruiting
  • Multiple Myeloma
  • Wuxi, Jiangsu, China
    Affiliated Hospital of Jiangnan University
Dec 15, 2022

Diabetic Foot Osteomyelitis Trial (Stimulan-VG, Systemic Antibiotics)

Not yet recruiting
  • Diabetic Foot Osteomyelitis
  • (no location specified)
Sep 15, 2022

Breast Cancer Trial in Birmingham ([89Zr]-Df-Trastuzumab, PET/MRI Imaging)

Recruiting
  • Breast Cancer
  • Birmingham, Alabama
    The Kirklin Clinic
Feb 1, 2022

Advanced Solid Tumor Trial in Amsterdam, Groningen (89Zr-S095012 tracer and S095012 will be administered via an IV infusion)

Recruiting
  • Advanced Solid Tumor
  • 89Zr-S095012 tracer and S095012 will be administered via an IV infusion
  • Amsterdam, Netherlands
  • +1 more
Dec 9, 2022

Pancreatic Cancer Trial in Grand Rapids (NMK89)

Recruiting
  • Pancreatic Cancer
  • Grand Rapids, Michigan
    BAMF Health
Nov 8, 2023

Pancreas Cancer Trial in Stanford (89Zr-panitumumab)

Suspended
  • Pancreas Cancer
  • Stanford, California
    Stanford University
Jun 15, 2022

Glioblastoma, GBM, Glioblastoma Multiforme Trial in Los Angeles, Boston, New York (Nivolumab-Placebo, Nivolumab,

Recruiting
  • Glioblastoma
  • +3 more
  • Nivolumab-Placebo
  • +4 more
  • Los Angeles, California
  • +3 more
Jan 16, 2023

Prostate Cancer Trial in New York (huJ591, 89Zr-J591)

Completed
  • Prostate Cancer
  • New York, New York
    Weill Cornell Medical College
Oct 1, 2020

Locally Advanced or Metastatic Solid Tumors Trial in Groningen (MPDL3280A)

Recruiting
  • Locally Advanced or Metastatic Solid Tumors
  • Groningen, Netherlands
    University Medical Center Groningen
Feb 28, 2022

Locally Advanced or Metastatic Solid Tumors Irrespective of PD-L1 Expression Trial in Groningen (89Zr-MPDL-3280A-PET scans)

Active, not recruiting
  • Locally Advanced or Metastatic Solid Tumors Irrespective of PD-L1 Expression
  • 89Zr-MPDL-3280A-PET scans
  • Groningen, Netherlands
    University Medical Center Groningen
Feb 28, 2022

Head-and-neck Squamous Cell Carcinoma Trial in San Francisco (89Zr-panitumumab IV, Panitumumab)

Not yet recruiting
  • Head-and-neck Squamous Cell Carcinoma
  • San Francisco, California
    Stanford Cancer Institute
Jun 14, 2022

Non Small Cell Lung Cancer Trial in Nijmegen (89Zr-avelumab PET, Avelumab)

Completed
  • Non Small Cell Lung Cancer
  • Nijmegen, Netherlands
    Radboud University
Jan 6, 2022

NSCLC Trial in Heidelberg (89Zirconium-M7824, M7824)

Terminated
  • Non-Small Cell Lung Cancer
  • Heidelberg, Victoria, Australia
    Austin Health
Jan 13, 2023

Bladder Cancer Trial in Saint Herblain (89Zr-TLX250 PET/CT)

Recruiting
  • Bladder Cancer
  • 89Zr-TLX250 PET/CT
  • Saint Herblain, France
    Institut de cancerologie de l'Ouest
Nov 24, 2021

Advanced NSCLC Trial (fianlimab, cemiplimab, Placebo)

Not yet recruiting
  • Advanced Non-Small Cell Lung Cancer
  • (no location specified)
Mar 27, 2023

89Zr-Bevacizumab PET/CT Imaging in NF2 Patients

Recruiting
  • Neurofibromatosis 2
  • Bevacizumab Zirconium Zr-89
  • Leiden, Zuid-Holland, Netherlands
    Leiden University Medical Center
Jan 5, 2023